vascuCAP vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent rather than direct competitors, both leveraging AI within cardiology but for distinct purposes. Tool A, vascuCAP, specializes in non-invasive CT angiography analysis to quantify plaque composition and assess cardiovascular risk for treatment optimization. In contrast, Tool B, IM007, focuses on remote cardiac monitoring by aggregating data from cardiac implantable electronic devices to streamline workflows and manage alerts.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
vascuCAP (now ElucidVivo/PlaqueIQ) is an AI software for non-invasive CT angiography analysis, quantifying plaque composition and assessing cardiovascular risk to optimize treatment decisions. IM007 is an AI-powered, cloud-based platform for remote cardiac monitoring, aggregating data from all cardiac implantable electronic devices (CIEDs) to streamline workflows, reduce false alerts, and improve patient outcomes in cardiology and heart failure management.
vascuCAP analyzes non-invasive CT angiograms to quantify plaque composition and characterize features like lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage. IM007 aggregates and analyzes data from various cardiac implantable electronic devices (CIEDs) from manufacturers such as Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort.
vascuCAP uses AI for CT angiogram analysis, providing histologically-validated plaque quantification and risk stratification for stroke and heart attack. IM007 employs AI for alert management to reduce false positives (e.g., 79% for ILR ECG Analyzer, 85% for AF alerts), offers an FDA-cleared AI for ICM ECG data analysis (ILR ECG Analyzer), and includes predictive AI for heart failure hospitalization risk (SignalHF).
vascuCAP is designed for Cardiology, Radiology, and Vascular Surgery specialties. IM007 primarily serves Cardiology and Hospital Medicine.
vascuCAP quantifies lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage, supporting personalized treatment decisions and risk stratification for stroke and heart attack. IM007 offers AI-driven alert management, an FDA-cleared ILR ECG Analyzer for ICM ECG data analysis, and SignalHF, an FDA-cleared predictive AI for heart failure hospitalization risk.